Form 8.3 - Willis Towers Watson plc - Amendment

LONDON--(BUSINESS WIRE)-- 

Ap19

FORM 8.3 - Amendment to Purchase and Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Barclays PLC.
Company dealt in	WILLIS TOWERS WATSON PLC
Class of relevant security to which the	ORD
dealings being disclosed relate (Note 2)
Date of dealing	14 October 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		2,567,346	1.99%	468,287	0.36%
(2)	Derivatives (other than options):
		594,656	0.46%	388,524	0.30%
(3)	Options and agreements to
	purchase/sell:	0	0.00%	0	0.00%
	TOTAL:
		3,162,002	2.45%	856,811	0.66%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	1	213.1200   USD
Purchase	1	212.3600   USD
Purchase	9	212.9700   USD
Purchase	71	213.0300   USD
Purchase	76	213.4600   USD
Purchase	84	213.9700   USD
Purchase	88	213.1100   USD
Purchase	91	213.2274   USD
Purchase	100	212.9600   USD
Purchase	100	212.8800   USD
Purchase	100	214.3200   USD
Purchase	185	213.6105   USD
Purchase	190	212.5764   USD
Purchase	200	213.3850   USD
Purchase	200	213.2625   USD
Purchase	227	212.5500   USD
Purchase	495	213.1393   USD
Purchase	775	213.0199   USD
Purchase	924	212.7711   USD
Purchase	1,320	212.9679   USD
Purchase	1,472	212.5300   USD
Purchase	1,801	213.0352   USD
Purchase	2,377	212.5425   USD
Purchase	2,671	213.0132   USD
Purchase	4,310	213.4722   USD
Purchase	6,010	213.3334   USD
Purchase	6,540	213.0091   USD
Purchase	6,739	212.6699   USD
Purchase	10,621	213.0160   USD
Purchase	12,975	213.1448   USD
Purchase	13,580	213.4109   USD
Purchase	18,080	212.6954   USD
Sale	42	212.6400   USD
Sale	50	212.9700   USD
Sale	91	213.2274   USD
Sale	100	212.6600   USD
Sale	185	213.6105   USD
Sale	192	212.5781   USD
Sale	213	212.5438   USD
Sale	276	213.4057   USD
Sale	344	212.9408   USD
Sale	377	212.7315   USD
Sale	688	212.5996   USD
Sale	760	213.2861   USD
Sale	1,036	213.4773   USD
Sale	1,078	212.9172   USD
Sale	1,119	212.6894   USD
Sale	1,324	213.2600   USD
Sale	1,335	213.8022   USD
Sale	1,472	212.5300   USD
Sale	1,546	213.1866   USD
Sale	2,057	212.6064   USD
Sale	2,377	212.5425   USD
Sale	2,382	213.0458   USD
Sale	3,275	213.3508   USD
Sale	5,516	213.3719   USD
Sale	8,452	212.4884   USD
Sale	9,765	213.4581   USD
Sale	14,333	213.1497   USD
Sale	31,750	212.9327   USD

(b) Derivatives transactions (other than options transactions)

Product Name	Nature of transaction	Number of relevant securities	Price per
			unit
SWAP	Long	1	344,592,140.0000   USD

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?	NO
Date of disclosure:	19 Oct 2020
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection